Prosecution Insights
Last updated: April 19, 2026

Curevac Netherlands B V

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17263258 CANCER VACCINES FOR UTERINE CANCER VAN DRUFF, SYDNEY 1643 Non-Final OA Jan 26, 2021
17262999 ARID1A, CDKN2A, KMT2B, KMT2D, TP53 and PTEN VACCINES FOR CANCER VAN DRUFF, SYDNEY 1643 Final Rejection Jan 25, 2021

Managing Curevac Netherlands B V's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month